InterCure (NASDAQ:INCR) Shares Up 1%

InterCure Ltd. (NASDAQ:INCR)’s share price traded up 1% during trading on Monday . The stock traded as high as $2.16 and last traded at $2.03. 70,464 shares changed hands during trading, a decline of 4% from the average session volume of 73,210 shares. The stock had previously closed at $2.01.

InterCure Price Performance

The company has a quick ratio of 1.38, a current ratio of 1.85 and a debt-to-equity ratio of 0.23. The stock’s 50 day moving average price is $2.75 and its two-hundred day moving average price is $2.15. The firm has a market capitalization of $96.61 million, a price-to-earnings ratio of 16.31 and a beta of 1.51.

Hedge Funds Weigh In On InterCure

A hedge fund recently bought a new stake in InterCure stock. Tidal Investments LLC purchased a new stake in shares of InterCure Ltd. (NASDAQ:INCR) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 325,741 shares of the company’s stock, valued at approximately $883,000. Tidal Investments LLC owned 0.71% of InterCure at the end of the most recent reporting period. Hedge funds and other institutional investors own 8.34% of the company’s stock.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.